<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F34AC300-EA0B-49AC-9DE8-DF4287E54B4F"><gtr:id>F34AC300-EA0B-49AC-9DE8-DF4287E54B4F</gtr:id><gtr:name>The Garvan Institute for Medical Research</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:department>Biology and Biochemistry</gtr:department><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F34AC300-EA0B-49AC-9DE8-DF4287E54B4F"><gtr:id>F34AC300-EA0B-49AC-9DE8-DF4287E54B4F</gtr:id><gtr:name>The Garvan Institute for Medical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4A52C5ED-044B-4554-8B77-96B319C11EC9"><gtr:id>4A52C5ED-044B-4554-8B77-96B319C11EC9</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Holman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9225018"><gtr:id>7CBF2760-A517-4C09-90EB-04CF255FF719</gtr:id><gtr:title>Functional analysis and pathophysiology of glucose transporters</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9225018</gtr:grantReference><gtr:abstractText>The health problem of type 2 diabetes is now huge with approximately 3% of the UK population (1.4 million people) suffering from the disease. This was once considered an adult onset disease but now teenagers are developing the disease. Sugars are abundant components of diet but their abnormal disposal is associated with type 2 diabetes. Improved understanding of glucose disposal by key body tissues is therefore needed. 
Diabetes is one of the major contributors to death from coronary heart disease. The uptake of sugars in heart is insulin stimulated but this process can be inhibited if the interior of the heart cells becomes too acidic. We plan to study the mechanism of heart cell pH maintenance and investigate the means by which this is linked to impaired glucose uptake and utilisation. Improved understanding will aid in the development of heart disease therapies. 
The increasing prevalence of type 2 diabetes is thought to be in part related to poor diets, and in part due to lack of exercise. We plan to study these two inter-related problems by focussing part of our programme on the processes in heart and skeletal muscle that govern the exposure of glucose uptake protein to the cell surface. This exposure can be driven by both insulin and by changes in the cell energy level resulting from exercise. We plan to utilise newly developed tools and reagents to study how the latter pathway can lead to alleviation of the poor insulin-stimulated glucose disposal found in type 2 diabetic persons. Integrating these related aspects of our investigation in the key tissues of fat, heart and muscle should add to the understanding of the delicate balance between our dietary sugar needs and excesses and this should lead to improved therapies that rebalance body chemistry.</gtr:abstractText><gtr:technicalSummary>Sugars are abundant components of diet but their abnormal disposal gives rise to diseases that include obesity and type 2 diabetes. Sugar disposal occurs via uptake into selective tissues that utilise specialised membrane tranporters or GLUTs. Recent genome analysis has indicated that the GLUT family of proteins includes some new un-characterised isoforms. We plan to examine the substrate specificity of the newly discovered GLUT8 and to analyse the extent to which it may rate limit sugar uptake in its target tissues. The extent to which GLUT8 contributes to glucose disposal will be examined by characterising GLUT8 in normal placenta and in placenta from animals which have been subjected to dietary and genetic modification. Such studies are relevant to dietary recommendations in diabetic pregnancies and the programming of adult onset syndrome X phenotypes. 
 In insulin responsive tissues GLUT4 distribution is particularly important for regulation of blood glucose levels. In type 2 diabetes, there is impaired insulin-stimulated GLUT4 recruitment from its intracellular storage compartment to the cell surface. We plan to investigate the role of cell pH maintenance in the subcellular movement of GLUT4. The localisation of cellular pH maintenance machinery will be examined. There will be emphasis on pH regulation in heart as the cell alkalinising and glucose disposal effects of insulin may be cardioprotective during ischemia. We plan to resolve the extent to which GLUT4 vesicle coating and fusion reactions are dependent on insulin?s action on pH and the extent to which the pH within GLUT4 vesicles is regulated.. 
 In addition to insulin, the hypoxia/exercise pathway leads to stimulation of glucose transport in heart and skeletal muscle. We plan to examine GLUT4 trafficking kinetics, compartmentalisation and phosphorylation in response to these stimuli. We plan to examine the extent to which the hypoxia/exercise pathway can partially mimic and compensate for impaired insulin action on GLUT4 subcellular trafficking. These mechanisms will be studied in human muscle from healthy and type 2 diabetic persons.</gtr:technicalSummary><gtr:fund><gtr:end>2009-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1993-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2195889</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CASE1</gtr:description><gtr:id>29683A16-99C6-4913-8450-9155E1617699</gtr:id><gtr:impact>Publication ID 19915010</gtr:impact><gtr:outcomeId>F3F9EB24245-1</gtr:outcomeId><gtr:partnerContribution>shared expertise</gtr:partnerContribution><gtr:piContribution>Setting up of assays for measuring GLUT4 translocation in a muscle cell line</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Garvan Institute for Medical Research</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Proteomics of insulin action on GLUT4</gtr:description><gtr:id>E226AC1B-024F-4ECF-8077-ED920D2044BA</gtr:id><gtr:impact>New data</gtr:impact><gtr:outcomeId>AUedSyTZNKA-1</gtr:outcomeId><gtr:partnerContribution>Proteomic analysis</gtr:partnerContribution><gtr:piContribution>Supply of material for analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Health Bath</gtr:department><gtr:description>Breakfast project</gtr:description><gtr:id>587B3DDE-A59A-4BF0-9C02-AA8749D67B25</gtr:id><gtr:impact>Publication in Trials</gtr:impact><gtr:outcomeId>D8ajnADAkAw-1</gtr:outcomeId><gtr:partnerContribution>Application of insulin sensitivity assays to human subjects under varying fasting regimes</gtr:partnerContribution><gtr:piContribution>Setting up assays for determining insulin sensitivity in adipose tissue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital D?sseldorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Diabetes Center</gtr:department><gtr:description>Diabetes Institute, Dusseldorf</gtr:description><gtr:id>71765ED7-9F42-4602-9EE0-2CBDA1E9E6B6</gtr:id><gtr:impact>Unpublished data
Sabbatical visit to the German Diabetes Centre in 2013 sponsored by DAAD</gtr:impact><gtr:outcomeId>VLCaiepTCwU-1</gtr:outcomeId><gtr:partnerContribution>Collaboratively we are studying the GTPase labelling in knockout animals with deletions in TBC1D1 and TBC1D4 that have been generated by the Dr Hadi Al Hasani at the German Diabetes Center</gtr:partnerContribution><gtr:piContribution>Generation of a new reagent for labelling the substrates of TBC1D1 and TBC1D4. These proteins are Rab GAPs</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at fundraisers meeting of Diabetes UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1DEB6866-BA24-4243-B253-B20D4FDDB28A</gtr:id><gtr:impact>about 30 Diabetes UK fundraisers attended

Discussions with audience and group occurred after presentation</gtr:impact><gtr:outcomeId>VfaskTvQiJx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Web site</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>CBDA08F0-1C80-4053-9EB5-ACAC4BD1F413</gtr:id><gtr:impact>General account of activities of our research on a web site that is publically accessible

Contacts from lay public</gtr:impact><gtr:outcomeId>129794EC63A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>213961</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Convergence of insulin signalling and GLUT4 trafficking at a regulated membrane fusion step)</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0BE16EAC-144B-4287-9913-7C0CBC5E89B0</gtr:id><gtr:outcomeId>5BFB75801590</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>143425</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Project Grant</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>3C79EA16-7D24-4AA6-A1CC-7D9CE44F39A2</gtr:id><gtr:outcomeId>B5B451488760</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Reagent for binding to activated form of GTPases</gtr:description><gtr:grantRef>G9225018</gtr:grantRef><gtr:id>AE2E6317-9522-49A4-B22E-3FFE0D9248A3</gtr:id><gtr:impact>Collaborative research with German Diabetes Center, Dusseldorf has been initiated</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>bZurpRhns7x</gtr:outcomeId><gtr:patentId>WO2012049464</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Reagent</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A GTP analogue that can detect the activation of GTP-binding proteins. This is being used to detect the activation of GTPase (mainly of the Rab family) that are relevant to insulin action in insulin responsive tissues such as adipose, heart and skeletal muscle</gtr:description><gtr:id>9EBFEC72-C6BF-4056-AD3B-8E13BF1764C9</gtr:id><gtr:impact>Patent</gtr:impact><gtr:outcomeId>rzZnuHSBghJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Photolabel for GTP binding proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a photoaffinity labelling reagent which can be used to study glucose transporters at the surface of cells. We have used it to determine the extent to which the glucose transporter GLUT4 is translocated in response to insulin and how this process is impaired in type 2 diabetes</gtr:description><gtr:id>0658C94E-41D3-4EE5-93F0-0CF34893BCF8</gtr:id><gtr:impact>Used with clinical samples including muscle from type 2 diabetes patients. This was a collaborative study with a group at the Karolinska Institute, Stockholm, Sweden</gtr:impact><gtr:outcomeId>6D52E0BE5C3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Photochemical reagent for analysis of GLUT4 translocation</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>C13 isotope tags on GTP photolabel. For use inproteomic analysis of GTP binding proteins</gtr:description><gtr:id>BEB92642-3725-48A4-A83F-1E6C7373E4A5</gtr:id><gtr:impact>Unpublished data</gtr:impact><gtr:outcomeId>pgrfVYKqUpz</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Isotope tags on GTP photolabels</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>49FDF390-4F3B-4A4D-B8CB-E4BE74525765</gtr:id><gtr:title>Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>848C6C99184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBD437E5-87F7-4697-9703-61621B24A355</gtr:id><gtr:title>Regulating the motor for GLUT4 vesicle traffic.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26706a910ee9fec6f94954eecde88210"><gtr:id>26706a910ee9fec6f94954eecde88210</gtr:id><gtr:otherNames>Holman GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>B53279DCACD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8A8BD21-9509-46B9-837F-C2472195A40A</gtr:id><gtr:title>Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c6b460790cf0.16733131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6A84FB1-2BD2-41B7-BDC2-1326CB4E512E</gtr:id><gtr:title>A novel transgenic line using the Cre-lox system to allow permanent lineage-labeling of the zebrafish neural crest.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c46dc1e84933ab76a7f41f90315553e"><gtr:id>7c46dc1e84933ab76a7f41f90315553e</gtr:id><gtr:otherNames>Rodrigues FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn><gtr:outcomeId>pm_15560_20_22522888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B677DF9-C1E7-469F-A31F-B5D5947E42A0</gtr:id><gtr:title>&amp;quot;Deletion of both Rab-GTPase-activating proteins TBC1D1 and TBC1D4 in mice eliminates insulin- and AICAR-stimulated glucose transport [corrected].</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ba2f0c2bdaf979e5a97dad528d7aea0"><gtr:id>3ba2f0c2bdaf979e5a97dad528d7aea0</gtr:id><gtr:otherNames>Chadt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>546214ea7cc2c1.06571495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6D22A18-979D-409D-ACBF-65CB34EEC006</gtr:id><gtr:title>Physiological and molecular responses to an acute bout of reduced-exertion high-intensity interval training (REHIT).</gtr:title><gtr:parentPublicationTitle>European journal of applied physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24734a5f63c91c27db0be5013b8e15c2"><gtr:id>24734a5f63c91c27db0be5013b8e15c2</gtr:id><gtr:otherNames>Metcalfe RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1439-6319</gtr:issn><gtr:outcomeId>58c6b460d67086.22639443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AAE1A30-3A86-4DC2-8E42-0948227BB478</gtr:id><gtr:title>Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>7A8D8903100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>539580ED-C46E-4709-947C-AB89AA6798AD</gtr:id><gtr:title>Bath Breakfast Project (BBP)--examining the role of extended daily fasting in human energy balance and associated health outcomes: study protocol for a randomised controlled trial [ISRCTN31521726].</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d695ac1431dd75c370be60a9980cb1e5"><gtr:id>d695ac1431dd75c370be60a9980cb1e5</gtr:id><gtr:otherNames>Betts JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5462184f149e46.51433385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8440BC8C-395D-48DF-8218-DD0F70C01AC7</gtr:id><gtr:title>Insulin regulates Rab3-Noc2 complex dissociation to promote GLUT4 translocation in rat adipocytes.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>5675e5702c430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9832940D-06EF-4839-A9BF-076CD3D29DA1</gtr:id><gtr:title>AS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>aCFpS8Jd9KK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C09CA5B5-E12D-4F35-BA37-89CCF4DCC782</gtr:id><gtr:title>FGT-1 is the major glucose transporter in C. elegans and is central to aging pathways.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89e37983f3278f9c30f6594c27c0aa4a"><gtr:id>89e37983f3278f9c30f6594c27c0aa4a</gtr:id><gtr:otherNames>Feng Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14275_25_24024580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F36BAEE-1B0C-422A-8646-E889F81CEC16</gtr:id><gtr:title>A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy-status signalling.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>668AFD4E986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC2B86E0-3215-4D33-865C-AF2AC243A65A</gtr:id><gtr:title>Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte responses to insulin and energy-status signalling.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccb286129508058a760f81ea6c52eea1"><gtr:id>ccb286129508058a760f81ea6c52eea1</gtr:id><gtr:otherNames>Lawrence SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>E1D187BE_0E1D187BE_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E35A62D-43F0-4C64-A004-BFA9C829BCBE</gtr:id><gtr:title>Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091d02cfdda8e008b3519583ad186a2c"><gtr:id>091d02cfdda8e008b3519583ad186a2c</gtr:id><gtr:otherNames>Nathubhai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>58c6b45fd84679.44381481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49D2641C-70E7-466F-B760-3456BC393A12</gtr:id><gtr:title>Insulin signaling meets vesicle traffic of GLUT4 at a plasma-membrane-activated fusion step.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>pm_14275_15_16154100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF8570C2-3BAE-458C-8824-C19E22148CC4</gtr:id><gtr:title>Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b82cf28b98a880d0dd4505fac4534f"><gtr:id>d3b82cf28b98a880d0dd4505fac4534f</gtr:id><gtr:otherNames>Sakamoto K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>4A3BB82DCE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2328E663-94F0-40AC-82E6-4DAFB1216DDA</gtr:id><gtr:title>Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c95c41618ce2af00eb9a82e0371429e"><gtr:id>0c95c41618ce2af00eb9a82e0371429e</gtr:id><gtr:otherNames>Rib? D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_14275_15_15661859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D4C45ED-1A86-441A-BFFE-6D92152C5B43</gtr:id><gtr:title>Kinetics of GLUT4 trafficking in rat and human skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9676fb6b36c74200b87479a035f49251"><gtr:id>9676fb6b36c74200b87479a035f49251</gtr:id><gtr:otherNames>Karlsson HK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>609163E9FCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31154882-8F7F-457A-9A1E-2B407A05AF3F</gtr:id><gtr:title>The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d695ac1431dd75c370be60a9980cb1e5"><gtr:id>d695ac1431dd75c370be60a9980cb1e5</gtr:id><gtr:otherNames>Betts JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>5462184f39a3f5.32413407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCFF49C2-D052-4F0B-ABBD-6A82C374460F</gtr:id><gtr:title>GLUT4 traffic through an ESCRT-III-dependent sorting compartment in adipocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14275_25_23049745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8901429E-EED0-421E-B6B2-1581C8F44D1F</gtr:id><gtr:title>Thrifty Tbc1d1 and Tbc1d4 proteins link signalling and membrane trafficking pathways.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>53C14A76474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>286C9556-CD12-424C-B284-9DA73F390328</gtr:id><gtr:title>Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6e95a5abb4dadf074fb1d8ba8568ab3"><gtr:id>b6e95a5abb4dadf074fb1d8ba8568ab3</gtr:id><gtr:otherNames>Miller EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>652EFDE7927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68A41629-097E-4AA4-AFE4-56701992AD42</gtr:id><gtr:title>Deletion of both Rab-GTPase-activating proteins TBC14KO and TBC1D4 in mice eliminates insulin- and AICAR-stimulated glucose transport. Diabetes 2015;64:746-759.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ba2f0c2bdaf979e5a97dad528d7aea0"><gtr:id>3ba2f0c2bdaf979e5a97dad528d7aea0</gtr:id><gtr:otherNames>Chadt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58c6b460a2dbf6.05224182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC852C9A-4BBC-4742-80C7-830E56030085</gtr:id><gtr:title>The causal role of breakfast in energy balance and health: a randomized controlled trial in obese adults.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0a51170617cc19edd56b1011ec24879"><gtr:id>b0a51170617cc19edd56b1011ec24879</gtr:id><gtr:otherNames>Chowdhury EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>58c6b4601ce2a7.75576459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>908E5894-58D5-4E96-B0E0-B342FF228DA0</gtr:id><gtr:title>Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14275_15_15557332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC8594F5-DC05-4736-AC15-4BAACDD1BF93</gtr:id><gtr:title>Rab28 is a TBC1D1/TBC1D4 substrate involved in GLUT4 trafficking.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf1ecd4c4c7b837a4d6237fe9fed466"><gtr:id>2bf1ecd4c4c7b837a4d6237fe9fed466</gtr:id><gtr:otherNames>Zhou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>58c6b460489a54.05785255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F20CFCF-604E-4245-A1FA-550234038A15</gtr:id><gtr:title>Developmental programming mediated by complementary roles of imprinted Grb10 in mother and pup.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5c733365c4db4772c714fc0f961435"><gtr:id>ec5c733365c4db4772c714fc0f961435</gtr:id><gtr:otherNames>Cowley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>doi_55f944944a1bfd32</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9225018</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>